Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Conventional neuromuscular blockade-Seoul National University Hospital refers to a specific treatment arm in a clinical trial (NCT02249585) evaluating anesthetic techniques during laparoscopic colon surgery. This protocol involves the administration of rocuronium, a non-depolarizing neuromuscular blocking agent, to maintain a moderate level of muscle relaxation, defined by a train-of-four (TOF) count of 1-2. Rocuronium acts as a competitive antagonist at nicotinic acetylcholine receptors at the neuromuscular junction, effectively blocking the action of acetylcholine and preventing muscle contraction. The trial, conducted by Seoul National University Hospital, compared this conventional approach against deep neuromuscular blockade to assess its impact on surgical conditions and cardiopulmonary function in patients in the Trendelenburg position.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Conventional neuromuscular blockade-Seoul National University Hospital.